Pursue Wealth Partners’s Ascendis Pharma A/S ASND Stock Holding History

Pursue Wealth Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Hold	1,451	–	–	0.22%	71
2026 Q1	$332K	Hold	1,451	–	–	0.2%	74
2025 Q4	$309K	Hold	1,451	–	–	0.15%	79
2025 Q3	$288K	Hold	1,451	–	–	0.16%	89
2025 Q2	$250K	Hold	1,451	–	–	0.14%	100
2025 Q1	$226K	Buy	+1,451	New	+$207K	0.14%	108
2024 Q4	–	Sell	-1,451	Closed	-$217K	–	117
2024 Q3	$217K	Buy	+1,451	New	+$196K	0.12%	104
2024 Q2	–	Sell	-1,451	Closed	-$219K	–	113
2024 Q1	$219K	Buy	+1,451	New	+$207K	0.13%	96
2022 Q2	–	Sell	-1,451	Closed	-$166K	–	125
2022 Q1	$166K	Buy	+1,451	New	+$168K	0.07%	140

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pursue Wealth Partners's ASND Position: Q2 2026 in Review

Pursue Wealth Partners held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 1,451 shares worth $387K. The position accounts for 0.22% of the portfolio, ranked #71.

Pursue Wealth Partners first reported a position in ASND in Q1 2022 and has held it in 9 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Pursue Wealth Partners held 1,451 shares of Ascendis Pharma A/S worth $387K as of Q2 2026.
Pursue Wealth Partners left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up 0.22% of Pursue Wealth Partners's portfolio in Q2 2026, its #71 holding.
Pursue Wealth Partners first reported a position in Ascendis Pharma A/S in Q1 2022 and has held it in 9 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Pursue Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.